The board of directors of Baxter International Inc (NYSE:BAX) declared a quarterly dividend of USD0.22 per share of the company's common stock, it disclosed on Tuesday.
This cash dividend will be paid on 1 October 2019 to shareholders of record as of 30 August 2019.
Annually, the dividend rate is equivalent t0 USD0.88 per share of common stock, according to the company.
With products, technologies and therapies available in 100 countries, Baxter's portfolio consist of critical care, nutrition, renal, hospital as well as surgical products.
AMGEN announces Q3 2026 dividend
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Aptamer Group launches Optimer-based Ebola diagnostic programme
SK bioscience to lead Gates Foundation-funded ROTOR project
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases
Gilead Sciences mobilises remdesivir donation to support Ebola response in Uganda
INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100
Lilly declares Q2 2026 dividend
Collegium to acquire AZSTARYS from Corium Therapeutics
CVS Health announces quarterly dividend of USD0.665 per share